COMMUNIQUÉS West-GlobeNewswire

-
Novartis announces change in Sandoz leadership
14/03/2019 -
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS
14/03/2019 -
Extendicare Announces Exit from B.C. Market in 2020
14/03/2019 -
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019
14/03/2019 -
Protalix BioTherapeutics to Postpone the 2018 Financial Results and Corporate Update Conference Call
13/03/2019 -
ADMA Biologics Reports Full Year 2018 Financial Results
13/03/2019 -
Zafgen to Present at the 31st Annual ROTH Conference
13/03/2019 -
iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18
13/03/2019 -
Axovant Sciences Announces Public Offering of Common Shares
13/03/2019 -
Harpoon Therapeutics to Participate in Upcoming William Blair Cancer Immunotherapy Conference
13/03/2019 -
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
13/03/2019 -
miRagen Announces Fourth Quarter and Full Year 2018 Financial Results and Provides 2019 Outlook
13/03/2019 -
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time
13/03/2019 -
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2018 Financial Results on March 28, 2019
13/03/2019 -
Melinta Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019 -
Sanofi successfully prices EUR 2 billion of bond issues
13/03/2019 -
Sanofi place des emprunts obligataires de 2 milliards d'euros
13/03/2019 -
Crossject : Résultats annuels 2018 et point d'activité
13/03/2019 -
FlexDex Provides Improved Solution to Prostate Surgery in Italy
13/03/2019
Pages